Document Detail


Mechanical protection of cardiac microcirculation during percutaneous coronary intervention of saphenous vein grafts.
MedLine Citation:
PMID:  15771915     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Saphenous vein bypass grafts permeability is one of the most important limitations of open heart surgery. The risks associated with surgical re-intervention are greater than those associated with the initial procedure. While native coronary arteries usually have fixed, fibrotic or calcified atherosclerotic plaques, the disease in the vein grafts contains soft material. When this material is compressed during percutaneous angioplasty, there is an unfavorable immediate outcome due to distal embolization of thrombus and plaque debris. In addition, the risk of post-procedure adverse events are higher when the grafts have a long time of implantation, due to a greater risk of branch occlusion or no-reflow at the adjacent microcirculation. The clinical consequence is a Non-Q-Wave Myocardial Infarction that is reflected in the increased serum cardiac enzymes. It is because of this complication that the distal protection devices were developed. The purpose of this paper is to review and discuss the current data on the distal protection devices available now for the treatment of degenerative saphenous vein graft disease. Currently, there are two distal protection devices approved in the United States: the Guardwire Balloon and Aspiration (Export) System and the Filter Wire EX. Other devices like the Triactiv System, Angioguard XP/ECW, DOW, MedNova Cardioshield, Medtronic-AVE DPD and the E-Trap Filter are still being studied. The first observational studies showed the safety and efficacy of the approved devices. A large randomized trial initially confirmed a significant decrease of in-hospital and 30-day cardiac adverse events, mainly Non-Q-Wave Myocardial Infarction, when angioplasty was performed with the assistance of the Guardwire System. Subsequently, another randomized study showed an equivalence between the Guardwire System and the Filter Wire EX. Distal protection devices have an acceptable performance, however, further technological improvements are warranted for a quick preparation, delivery and/or retrieval of these devices.
Authors:
Jorge Bejarano
Related Documents :
20146345 - Proximal protection in recanalization of totally occluded saphenous vein grafts in acut...
10567335 - The role of gene therapy for intimal hyperplasia of bypass grafts.
1079445 - Localization of tissue plasminogen activator in relation to morphologic changes in huma...
7149975 - In situ saphenous vein bypass.
9232955 - Retrograde cerebral perfusion with pharmacological cerebral protection in the repair of...
18185955 - Endovascular brachytherapy in the femoropopliteal segment using 192ir and 188re.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  International journal of cardiology     Volume:  99     ISSN:  0167-5273     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  2005 Mar 
Date Detail:
Created Date:  2005-03-17     Completed Date:  2005-07-15     Revised Date:  2006-07-12    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  365-72     Citation Subset:  IM    
Affiliation:
Miami Heart Institute, Cardiovascular Laboratory, 4701 North Meridian Avenue, Suite 3303, Miami Beach, FL 33140, USA. jorgebejarano@cardiol.br
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angioplasty, Transluminal, Percutaneous Coronary / adverse effects*
Coronary Artery Bypass
Coronary Circulation*
Coronary Disease / surgery
Graft Occlusion, Vascular / therapy*
Humans
Microcirculation
Prostheses and Implants*
Reoperation
Saphenous Vein / radiography,  transplantation
Stents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocyti...
Next Document:  Long term effects of hormone replacement therapy on heart rate variability, QT interval, QT dispersi...